annb0t
Top 20
AngioDynamics, Inc. ANGO reported adjusted earnings per share (âEPSâ) of a penny for fourth-quarter fiscal 2022 compared with the year-ago breakeven EPS. The Zacks Consensus Estimate for the same was in line with the reported figure.
GAAP loss per share came in at 16 cents, narrower than the year-ago loss of 51 cents.
Full-year adjusted EPS was at a breakeven level compared with adjusted EPS of 5 cents at the end of fiscal 2021. The metric surpassed the Zacks Consensus Estimate of a ...
>>> Read more: AngioDynamics (ANGO) Q4 Earnings in Line, Revenues Beat Mark
GAAP loss per share came in at 16 cents, narrower than the year-ago loss of 51 cents.
Full-year adjusted EPS was at a breakeven level compared with adjusted EPS of 5 cents at the end of fiscal 2021. The metric surpassed the Zacks Consensus Estimate of a ...
>>> Read more: AngioDynamics (ANGO) Q4 Earnings in Line, Revenues Beat Mark
